211 related articles for article (PubMed ID: 38651065)
1. Evaluation of bacterial safety approaches of platelet blood concentrates: bacterial screening and pathogen reduction.
Rezvany MR; Moradi Hasan-Abad A; Sobhani-Nasab A; Esmaili MA
Front Med (Lausanne); 2024; 11():1325602. PubMed ID: 38651065
[TBL] [Abstract][Full Text] [Related]
2. Impact of different pathogen reduction technologies on the biochemistry, function, and clinical effectiveness of platelet concentrates: An updated view during a pandemic.
Escolar G; Diaz-Ricart M; McCullough J
Transfusion; 2022 Jan; 62(1):227-246. PubMed ID: 34870335
[TBL] [Abstract][Full Text] [Related]
3. [Single-donor (apheresis) platelets and pooled whole-blood-derived platelets--significance and assessment of both blood products].
Hitzler WE
Clin Lab; 2014; 60(4):S1-39. PubMed ID: 24779310
[TBL] [Abstract][Full Text] [Related]
4. Pathogen-reduced platelets for the prevention of bleeding.
Estcourt LJ; Malouf R; Hopewell S; Trivella M; Doree C; Stanworth SJ; Murphy MF
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD009072. PubMed ID: 28756627
[TBL] [Abstract][Full Text] [Related]
5. Mirasol PRT system inactivation efficacy evaluated in platelet concentrates by bacteria-contamination model.
Jocić M; Trkuljić M; Jovicić D; Borovcanin N; Todorović M; Balint B
Vojnosanit Pregl; 2011 Dec; 68(12):1041-6. PubMed ID: 22352265
[TBL] [Abstract][Full Text] [Related]
6. Nationwide Implementation of Pathogen Inactivation for All Platelet Concentrates in Switzerland.
Jutzi M; Mansouri Taleghani B; Rueesch M; Amsler L; Buser A
Transfus Med Hemother; 2018 May; 45(3):151-156. PubMed ID: 29928168
[TBL] [Abstract][Full Text] [Related]
7. Pathogen-reduced platelets for the prevention of bleeding.
Butler C; Doree C; Estcourt LJ; Trivella M; Hopewell S; Brunskill SJ; Stanworth S; Murphy MF
Cochrane Database Syst Rev; 2013 Mar; (3):CD009072. PubMed ID: 23543569
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic methods for platelet bacteria screening: current status and developments.
Störmer M; Vollmer T
Transfus Med Hemother; 2014 Feb; 41(1):19-27. PubMed ID: 24659944
[TBL] [Abstract][Full Text] [Related]
9. Bacterial contamination of blood components: risks, strategies, and regulation: joint ASH and AABB educational session in transfusion medicine.
Hillyer CD; Josephson CD; Blajchman MA; Vostal JG; Epstein JS; Goodman JL
Hematology Am Soc Hematol Educ Program; 2003; ():575-89. PubMed ID: 14633800
[TBL] [Abstract][Full Text] [Related]
10. Platelet Pathogen Reduction Technologies Alter the MicroRNA Profile of Platelet-Derived Microparticles.
Diallo I; Benmoussa A; Laugier J; Osman A; Hitzler WE; Provost P
Front Cardiovasc Med; 2020; 7():31. PubMed ID: 32266291
[TBL] [Abstract][Full Text] [Related]
11. Storage medium of platelet transfusions and the risk of transfusion-transmitted bacterial infections.
Kreuger AL; Middelburg RA; Kerkhoffs JH; Schipperus MR; Wiersum-Osselton JC; van der Bom JG
Transfusion; 2017 Mar; 57(3):657-660. PubMed ID: 28144957
[TBL] [Abstract][Full Text] [Related]
12. In vitro platelet production for transfusion purposes: Where are we now?
Martínez-Botía P; Acebes-Huerta A; Seghatchian J; Gutiérrez L
Transfus Apher Sci; 2020 Aug; 59(4):102864. PubMed ID: 32646795
[TBL] [Abstract][Full Text] [Related]
13. Bacterial contamination of platelets for transfusion: strategies for prevention.
Levy JH; Neal MD; Herman JH
Crit Care; 2018 Oct; 22(1):271. PubMed ID: 30367640
[TBL] [Abstract][Full Text] [Related]
14. A comprehensive proteomics study on platelet concentrates: Platelet proteome, storage time and Mirasol pathogen reduction technology.
Salunkhe V; De Cuyper IM; Papadopoulos P; van der Meer PF; Daal BB; Villa-Fajardo M; de Korte D; van den Berg TK; Gutiérrez L
Platelets; 2019; 30(3):368-379. PubMed ID: 29553857
[TBL] [Abstract][Full Text] [Related]
15. Frequency of bacterial contamination of platelet concentrates before and after introduction of diversion method in Japan.
Satake M; Mitani T; Oikawa S; Nagumo H; Sugiura S; Tateyama H; Awakihara S; Mitsutomi Y; Muraoka M; Tadokoro K
Transfusion; 2009 Oct; 49(10):2152-7. PubMed ID: 19500321
[TBL] [Abstract][Full Text] [Related]
16. Current status of rapid bacterial detection methods for platelet components: A 20-year review by the ISBT Transfusion-Transmitted Infectious Diseases Working Party Subgroup on Bacteria.
Schmidt M; Ramirez-Arcos S; Stiller L; McDonald C;
Vox Sang; 2022 Aug; 117(8):983-988. PubMed ID: 35412655
[TBL] [Abstract][Full Text] [Related]
17. Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates.
Perez-Pujol S; Tonda R; Lozano M; Fuste B; Lopez-Vilchez I; Galan AM; Li J; Goodrich R; Escolar G
Transfusion; 2005 Jun; 45(6):911-9. PubMed ID: 15934989
[TBL] [Abstract][Full Text] [Related]
18. Residual risk and retrospective analysis of transfusion-transmitted bacterial infection reported by the French National Hemovigilance Network from 2000 to 2008.
Lafeuillade B; Eb F; Ounnoughene N; Petermann R; Daurat G; Huyghe G; Vo Mai MP; Caldani C; Rebibo D; Weinbreck P
Transfusion; 2015 Mar; 55(3):636-46. PubMed ID: 25257344
[TBL] [Abstract][Full Text] [Related]
19. Real-time polymerase chain reaction in transfusion medicine: applications for detection of bacterial contamination in blood products.
Dreier J; Störmer M; Kleesiek K
Transfus Med Rev; 2007 Jul; 21(3):237-54. PubMed ID: 17572262
[TBL] [Abstract][Full Text] [Related]
20. Bacterial detection of platelets: current problems and possible resolutions.
Blajchman MA; Beckers EA; Dickmeiss E; Lin L; Moore G; Muylle L
Transfus Med Rev; 2005 Oct; 19(4):259-72. PubMed ID: 16214015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
